TaiMed
Chinese Nationalist Party (KMT) lawmakers yesterday questioned the procedural legality of
the state-owned National Development Fund’s (NDF) investment in Yu Chang Biologics Co
in 2007, following the declassification of two documents relating to the investment.
中國國民黨 立法議員昨天質疑,
國家發展基金(NDF)在2007年投資 宇昌生物製品公司
(宇昌生技股份有限公司)程序的合法性,
接著公布解密投資有關的兩個文件。
In addition, legislators reiterated accusations against Democratic Progressive Party (DPP)
presidential candidate Tsai Ing-wen, who was vice premier at the time,
of privately profiting from the investment deal.
此外,立法議員重申指控 當時的行政院副院長
當今的民主進步黨(民進黨)的總統候選人蔡英文
從這項投資交易中有私人獲利。
相關文章
生技產業...我不熟 ...你我都不需要愛滋病的藥吧 !